Impact of screening with thyroid ultrasonography in myasthenia gravis patients

Acta Neurologica Scandinavica

Volumn 125, Issue 6, 2012, Pages 398-402

  Maruyama, E ^a   Minami, N ^a   Niino, M ^a   Fujiki, N ^a   Doi, S ^a   Watanabe, M ^a   Shima, K ^b   Kikuchi, S ^a   Sasaki, H ^c  

^a HOKKAIDO MEDICAL CENTER   (Japan)

^b Sapporo Neurology Clinic   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoma; Myasthenia gravis; Thymoma; Thyroid; Tumor; Ultrasonography

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; ATROPHY; CANCER STAGING; ECHOGRAPHY; EPITHELIUM HYPERPLASIA; FEMALE; GOITER; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PREVALENCE; SCREENING; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84860118732     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01580.x     Document Type: Article

References (15)

1. Kanazawa M, Shimohata T, Tanaka K, Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 2007;14:1403-4.
2. Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 2008;15:1029-33.
3. Gasent Blesa JM, Grande Pulido E, Provencio Pulla M et al. Old and new insights in the treatment of thyroid carcinoma. J Thyroid Res 2010;2010:279468.
4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-48.
5. Ito Y, Amino N, Miyauchi A. Thyroid ultrasonography. World J Surg 2010;34:1171-80.
6. Shimura H, Endo T, Ohta K, Hataguchi K, Onaya T, Wakabayashi T. Incidence of thyroid tumors and thyroid dysfunctions detected at ultrasonographic screening. Ningen Dock 2001;16:146-52 (in Japanese).
7. Kasagi K. Epidemiology of thyroid tumors: effect of environmental iodine intake. Nippon Rinsho 2007;65:1953-8 (in Japanese).
8. Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 2010;290:66-9.
9. Ito Y, Uruno T, Nakano K et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-7.
10. Bastin S, Bolland MJ, Croxson MS. Role of ultrasound in the assessment of nodular thyroid disease. J Med Imaging Radiat Oncol 2009;53:177-87.
11. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
12. Leenhardt L, Hejblum G, Franc B et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999;84:24-8.
13. Díaz-Manera J, Rojas-García R, Illa I. Treatment strategies for myasthenia gravis. Expert Opin Pharmacother 2009;10:1329-42.
14. Masaoka A, Monden Y. Comparison of the results of transsternal simple, transcervical simple, and extended thymectomy. Ann N Y Acad Sci 1981;377:755-65.
15. Toth C, Mcdonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand 2006;114:124-32.